Latest News  

Biosimilar ABP 798 Promising for RA

A clinical trial in RA patients has established the pharmacokinetic similarity of ABP 798 and rituximab… [Read More]

The Effects of Early RA Treatment on CVD

New research exploring the effects of etanercept on cardiovascular disease in treatment-naive, early RA patients suggests a treatment advantage with etanercept, a TNF inhibitor and methotrexate over treatment with methotrexate and a conventional synthetic disease-modifying anti-rheumatic drug… [Read More]

Ibuprofen an Option for Early Pain Control after Hip Replacement

NEW YORK (Reuters Health)—Combining paracetamol (acetaminophen) with ibuprofen does not cut postoperative use of morphine in a clinically meaningful way relative to ibuprofen alone, in… [Read More]

Large-Vessel Involvement Is an Independent Risk Factor Predicting GCA Mortality

At diagnosis, temporal artery biopsy results and large-vessel involvement of patients with giant cell arteritis may be stronger predictors of mortality than cardiovascular risk factors… [Read More]

Alterations in Macrophage Activation May Signal a Lupus Flare

New data suggest myeloid cells in SLE patients skew B and T cell activation status toward the M1 proinflammatory phenotype, thereby directing SLE flares and remission… [Read More]

Leading Support for Division Directors

The ACR has elected a small group of division directors from across the country to serve on the Division Directors Special Committee. The goals of… [Read More]

View More Latest News »